Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas
暂无分享,去创建一个
S. Kropf | C. Mawrin | E. Kirches | K. Dietzmann | C. Vorwerk | R. Firsching | U. Lendeckel | C. Grimm | T. Schneider | T. Sasse | C. Pambor
[1] S. Rhee,et al. Identification of Phospholipase C-γ1 as a Mitogen-activated Protein Kinase Substrate* , 2004, Journal of Biological Chemistry.
[2] B. Scheithauer,et al. Loss of Tumor Suppressor in Lung Cancer‐1 (TSLC1) Expression in Meningioma Correlates with Increased Malignancy Grade and Reduced Patient Survival , 2004, Journal of neuropathology and experimental neurology.
[3] S. Pyne,et al. Receptor tyrosine kinase-GPCR signal complexes. , 2003, Biochemical Society transactions.
[4] P. Malfertheiner,et al. Expression of carbonic anhydrase IX in human pancreatic cancer , 2003, Alimentary pharmacology & therapeutics.
[5] Mahlon D. Johnson,et al. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. , 2002, Journal of neurosurgery.
[6] A. Korshunov,et al. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. , 2002, Archives of pathology & laboratory medicine.
[7] P. Reilly,et al. Surgical Treatment of Nocardial Brain Abscesses , 2002, Neurosurgery.
[8] Arie Perry,et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. , 2002, The American journal of pathology.
[9] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[10] B. Scheithauer,et al. A Role for Chromosome 9p21 Deletions in the Malignant Progression of Meningiomas and the Prognosis of Anaplastic Meningiomas , 2002, Brain pathology.
[11] Ana Luisa Velasco,et al. Electrical Stimulation of the Prelemniscal Radiation in the Treatment of Parkinson’s Disease: An Old Target Revised with New Techniques , 2001, Neurosurgery.
[12] A. Woodard,et al. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. , 2001, Journal of neurosurgery.
[13] C. Marshall,et al. PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS , 2000, Oncogene.
[14] J. Smirniotopoulos. The new WHO classification of brain tumors. , 1999, Neuroimaging clinics of North America.
[15] Arie Perry,et al. “Malignancy” in meningiomas , 1999 .
[16] E. Chilvers,et al. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. , 1998, Molecular pharmacology.
[17] Michael F. Moran,et al. Requirement for Phospholipase C-γ1 Enzymatic Activity in Growth Factor-Induced Mitogenesis , 1998, Molecular and Cellular Biology.
[18] B. Scheithauer,et al. Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.
[19] P. Black,et al. Expression and activation of epidermal growth factor receptors in meningiomas. , 1997, Journal of neurosurgery.
[20] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] M. Koegl,et al. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Carroll,et al. Platelet-derived growth factor expression and stimulation in human meningiomas. , 1994, Journal of neurosurgery.
[23] R. Fahlbusch,et al. Accumulation of inositol phosphates in low-passage human meningioma cells following treatment with epidermal growth factor. , 1994, Journal of neurosurgery.
[24] Mahlon D. Johnson,et al. The epidermal growth factor receptor is associated with phospholipase C-γ1 in meningiomas , 1994 .
[25] B. Scheithauer,et al. The New WHO Classification of Brain Tumours , 1993, Brain pathology.
[26] H. Budka,et al. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. , 1992, Journal of neurosurgery.
[27] M. Prados,et al. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. , 1992, Neurosurgery.
[28] G. Carpenter,et al. Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells , 1989, Molecular and cellular biology.
[29] J. Jääskeläinen,et al. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. , 1986, Surgical neurology.
[30] J. Jääskeläinen,et al. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. , 1985, Surgical neurology.
[31] Dorothy S. Russell,et al. Pathology of Tumours of the Nervous System , 1960 .
[32] Mahlon D. Johnson,et al. Lovastatin is a Potent Inhibitor of Meningioma Cell Proliferation: Evidence for Inhibition of a Mitogen Associated Protein Kinase , 2004, Journal of Neuro-Oncology.
[33] B. Scheithauer,et al. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. , 1999, Cancer.
[34] N. Ahn,et al. Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.
[35] M. Wolter,et al. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. , 1998, Cancer research.
[36] O. Al-Mefty,et al. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. , 1996, Journal of neurosurgery.
[37] J. Jääskeläinen,et al. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. , 1992, Neurosurgery.